Literature DB >> 24280456

Caregivers of multiple myeloma survivors.

Sandra Kurtin1, Kathryn Lilleby, Jacy Spong.   

Abstract

Patients living with multiple myeloma (MM) face complex decisions throughout their journey relative to their diagnosis, options for treatment, and how their disease and treatment choices may affect them physically, emotionally, financially, and spiritually. Patients considering a hematopoietic stem cell transplantation face specific self-management challenges. The availability of a reliable caregiver is a prerequisite to transplantation eligibility. Currently, the majority of clinical management is episodic and provided in the outpatient setting. Therefore, the bulk of care for patients living with MM is provided by the patient together with his or her caregivers. Caregivers face similar challenges to those faced by the patient living with MM. They are required to take in complex information, perform often complicated or technical procedures such as line care or injections, assist the patient with activities of daily living, and attend the myriad of appointments required. Understanding the dynamics of the patient-caregiver relationship, the strengths and weaknesses unique to that relationship, common elements of caregiver stress or strain, and available tools and strategies to promote a sense of control and enhance self-management skills may improve the health-related quality of life for both the patient with MM and his or her caregiver.

Entities:  

Mesh:

Year:  2013        PMID: 24280456     DOI: 10.1188/13.CJON.S2.25-32

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  7 in total

1.  Social frailty predicts worse outcomes in patients with multiple myeloma: A novelty in an old approach.

Authors:  Toshiki Terao; Takafumi Tsushima; Daisuke Miura; Kentaro Narita; Masami Takeuchi; Kosei Matsue
Journal:  EJHaem       Date:  2020-06-17

Review 2.  Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.

Authors:  Tanya M Wildes; Erica Campagnaro
Journal:  J Geriatr Oncol       Date:  2016-04-23       Impact factor: 3.599

3.  Living with relapsed myeloma: Symptoms and self-care strategies.

Authors:  Orlaith Cormican; Maura Dowling
Journal:  J Clin Nurs       Date:  2018-03-15       Impact factor: 3.036

4.  Results of a Time and Motion Survey Regarding Subcutaneous versus Intravenous Administration of Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma.

Authors:  Mary Slavcev; Allison Spinelli; Elisabeth Absalon; Tara Masterson; Christoph Heuck; Annette Lam; Erwin De Cock
Journal:  Clinicoecon Outcomes Res       Date:  2021-06-08

5.  The work of managing multiple myeloma and its implications for treatment-related decision making: a qualitative study of patient and caregiver experiences.

Authors:  Cheryl Pritlove; Mobin Jassi; Bridget Burns; Arleigh McCurdy
Journal:  BMC Cancer       Date:  2021-07-08       Impact factor: 4.430

6.  Lack of health maintenance examinations and risk in myeloma patients.

Authors:  Joseph D Tariman; Charise Gleason; Beth Faiman; Deborah Doss; Donna Catamero; Jessica Bishop-Royse; Mike Katz; Sandra Kurtin; Diane Moran; Sagar Lonial
Journal:  Cancer Med       Date:  2016-04-27       Impact factor: 4.452

7.  Caregivers of Patients with Hematological Malignancies within Home Care: A Phenomenological Study.

Authors:  Isabella Capodanno; Mirta Rocchi; Rossella Prandi; Cristina Pedroni; Enrica Tamagnini; Pierluigi Alfieri; Francesco Merli; Luca Ghirotto
Journal:  Int J Environ Res Public Health       Date:  2020-06-05       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.